Professor David Haslam
Professor David Haslam was a GP in Ramsey, Cambridgeshire for many years. He was president of the British Medical Association (2011-12), President (2006-9) and chairman (2001-4) of the Royal College of General Practitioners (RCGP), and vice chairman of the Academy of Medical Royal Colleges. He is a visiting Professor in Primary Health Care at De Montfort University in Leicester. He is also a member of the National Quality Board and Chair of the NQB Quality Information Committee. He was formerly National Professional Advisor to the Care Quality Commission, and was chair of the NICE Evidence Accreditation Advisory Committee.
Professor Haslam chaired the Modernising Medical Careers Programme Board from 2007-9. He was co-chair of the NHS Future Forum Information subgroup, a member of the Postgraduate Medical Education Training Board, a member of NHS MEE, co-chair of the MMC Programme Board from 2006-9 and a board member of the Postgraduate Medical Education Training Board.
David is a Fellow of the RCGP, the Faculty of Public Health, the Academy of Medical Educators and the Royal College of Physicians. He has written 13 books, mainly on health topics for the lay public and translated into 13 languages, and well over a thousand articles for the medical and lay press. He was awarded the CBE in 2004 for services to Medicine and Health Care.
Andy is currently Vice Chair of NICE, a role in which he has the board responsibility for the Technology Appraisal Appeal process. Andy has been a Non-executive director at NICE since 2009.
He joined the Department of Health in 1976 after graduating from Cambridge University. He became a departmental board member as Director General of Policy and Planning in 2002 with oversight of the Department of Health's policy agenda for the reform and improvement of health and social care. His post also covered all aspects of pharmaceuticals and pharmacy and the clinical and cost effective use of medicines in the NHS.
Between 2003 and 2012 Andy was a managing director at the Audit Commission, responsible for all the Commission's work in the NHS and on health matters and for general management of the Commission's field force. Andy is currently an adjunct professor at the Institute of Global Health Innovation at Imperial College and a Non-executive Director of EMIS. He is a former trustee of the Nuffield Trust and is now interim chief executive.
Professor Sheena Asthana
Professor Sheena Asthana is Professor of Health Policy at the University of Plymouth. Her research and teaching focus is on inequalities in health and health care, international public health and evidence-based public health.
She has worked with NICE to produce systematic reviews, evidence synthesis and economic analyses to inform our public health programme. Sheena brings experience of a wide variety of board appointments.
Dr Rosie Benneyworth
Rosie works as a ‘Portfolio GP’ in Somerset with a role representing GP providers for the Somerset Sustainability and Transformation Plan (STP), and as a GP in and out of hours.
She has previously held roles as the Managing Director of the South West Academic Health Science Network and a Clinical Commissioner for several years in Somerset.
Rosie was a NICE Fellow 2013-2016, and was a member of the group that developed the NICE guideline on Urinary Incontinence in Women. She has been a Non-Executive Director with NICE since January 2016.
Professor Angela Coulter
Professor Angela Coulter is a health policy analyst and researcher, with special interests in patient and public involvement. Her previous roles include Chief Executive of Picker Institute Europe, Director of Policy and Development at the King’s Fund, Director of the Health Services Research Unit at the University of Oxford and Director of Global Initiatives at the Informed Medical Decisions Foundation.
Angela has published more than 300 research papers and reports. She is the author of several books including The European Patient of the Future, winner of the 2004 Baxter Award. Her work has received awards from the Donabedian Foundation of Barcelona in 2012 and the International Shared Decision Making Conference in 2013.
Professor Martin R Cowie
Professor Martin Cowie is Professor of Cardiology at Imperial College and an Honorary Consultant Cardiologist at the Royal Brompton and Harefield NHS Foundation Trust. Since 2003 he has been a clinical advisor for NICE on our acute and chronic heart failure guidelines, quality standards, commissioning guides, patient decision aids, and technology appraisals. In 2012 he became a NICE Specialty Advisor for cardiovascular interventions.
His major clinical and research interests are in health technology assessment and the delivery of efficient and effective care for patients with heart failure, focusing on new technologies: diagnostics, drugs or devices.
Elaine Inglesby-Burke has been a registered nurse since 1980. Her previous roles include being a nurse specialist manager at St Helens and Knowsley Hospital Trust and Director of Nursing at The Walton Centre in Liverpool. Most recently, Elaine was appointed Deputy Chief Executive at Salford Royal NHS Foundation Trust. She is also on the governing body at St Helens Clinical Commissioning Group and Willowbrook Hospice in St Helens.
Elaine has also played a significant role in national health campaigns, having been a member of the Prime Minister’s Nursing and Care Quality Forum. She was also involved with the Berwick National Advisory Group on the Safety of Patients in England, which is a group of healthcare experts that was set up to examine patient safety issues in the NHS.
Last year, Elaine was awarded a CBE on the Queen’s Birthday Honours List for her services to nursing.
Tim Irish has worked for 30 years in the healthcare industry, both in the UK and internationally.
From 2012 to 2015, he was Chairman of the Board of Directors of Nexstim plc - a medical technology company focusing on improving rehabilitation for stroke patients.
He has worked at a senior level in international companies which produce medical products. He was global head of marketing and strategy for Phillips Medical and a Vice President for GE Medical in Europe.
Before joining the Board at NICE, Tim held a number of non-executive roles at Board level in technology businesses.
Dr Rima Makarem
Dr Rima Makarem has been Audit Chair in several NHS organisations, recently at NHS London and now at University College London Hospital. She is also the Chair for the National Travel Health Network and Centre (NaTHNaC), an Independent Council Member at St George’s University of London and a Board Trustee at Anchor Trust, a leading national provider of care homes and sheltered accommodation.
Rima has previously worked in the pharmaceutical industry in a number of roles including Director of Competitive Excellence at GlaxoSmithKline.
Tom Wright CBE
Tom Wright CBE is Chief Executive of Age UK and is also chair of the Richmond Group of 14 leading health charities. Tom also sits on a range of health and social care bodies such as the Global Council on Brain Health.
Sir Andrew Dillon
Sir Andrew Dillon joined the NHS in 1975 and has held a number of senior management positions, including General Manager of the Royal Free Hospital and Chief Executive of St George's Healthcare NHS Trust. He joined the National Institute for Health and Care Excellence as its founding Chief Executive in 1999.
Professor Gillian Leng CBE
Deputy Chief Executive and Director of Health and Social Care
Professor Gillian Leng is the Deputy Chief Executive at NICE, the Director of Health and Social Care, and a visiting professor at King's College London.
Gillian trained in medicine at Leeds, and then spent several years researching the epidemiology of peripheral vascular disease at Edinburgh University. She was involved in the Cochrane Collaboration as it first became established, and still contributes as an editor to the EPOC Group (Effective Practice and Organisation of Care). She specialised in public health medicine, and worked as a consultant before moving to NICE in 2001.
At NICE, Gillian has been responsible for the initial set up and running of the clinical guidelines programme, for establishing the NICE implementation function, and for setting up NHS Evidence. More recently she has been responsible for the transfer of the National Prescribing Centre into NICE, for establishing the NICE accreditation programme, and for new work on Quality Standards across health and social care.
Gillian is also Director of the Health and Social Care Programme and since January 2015 is leading the public health team at NICE.
Director of Business Planning and Resources
Ben Bennett joined NICE in 2003. As director of business planning and resources, Ben is responsible for the Institute's business planning process and corporate services including finance, human resources, information technology, estates and facilities.
Ben graduated from the University of Keele with a degree in economics and computer science. He trained as an accountant on the NHS graduate financial management scheme and is a member of the Chartered Institute of Public Finance and Accountancy (CIPFA).
Before joining NICE Ben worked for the Audit Commission, where he was involved in a range of work including value for money reviews and financial audit for both health and local government clients. Before this he worked as a Finance Manager within the NHS.
Professor Carole Longson
Director, Centre for Health Technology Evaluation, NICE
Carole is Director of the Centre for Health Technology Evaluation at NICE. She has a doctorate in Pharmacology and spent 8 years at GlaxoSmithKline Research working on the development of novel pharmaceuticals in various therapeutic areas.
Carole has previously been involved in health technology assessment as Director of the Evidence Research Unit. She contributes to a number of international policy forums, including the WHO advisory group on Priority Medical Devices and the Scientific Committee of the Innovative Medicines Initiative. She is Honorary Professor of Health Technology Assessment at the University of Manchester, UK and currently President of Health Technology Assessment International.
Centre for Guidelines Director
Mark Baker is the Director of the Centre for Guidelines (CfG) and is responsible for designing and operating methods and systems to produce clinical guidelines for the NHS. CfG is also responsible for the work of the Medicines and Prescribing Centre including summaries of evidence on new medicines and unlicensed and off-label medicines and the management of the contract for the British National Formulary.
Before joining NICE, Mark was Lead Cancer Clinician at the Leeds Teaching Hospitals and National Clinical Lead for Cancer Peer Review. He has previously worked in transplantation, academic medicine and public health medicine and was Chief Executive of Bradford Teaching Hospitals for six years and a Director of Research and Development.
Jane Gizbert joined NICE in 2008 and is responsible for the delivery of the institute's strategic communications programme. Jane graduated from the University of New Brunswick in Canada with an BA Honours degree in Political Science. She subsequently obtained an MA in this field from Carleton University in Ottawa and went on to undertake a graduate journalism programme at the same university.
Immediately before joining NICE, Jane was head of corporate communications at the Medical Research Council, the UK's largest publicly funded medical research organisation. Her remit covered the full spectrum of corporate communications, from strategic development, public involvement and consultation, to media relations and brand management. Jane has worked extensively in the political field in Canada, including as Press secretary for the official opposition and former prime minister of Canada, and as Director of communications, Canadian Federation of Labour.
Jane has also held senior positions in charitable organisations including the Scout Association and the International Planned Parenthood Federation.
Director of Evidence Resources
Alexia Tonnel is director of Evidence Resources. She is responsible for the delivery of the NHS Evidence and UK PharmaScan services and leads the information management and technology, user research and information services resources of NICE.
Alexia studied business and management in France after which she completed a Master of Science in International Accounting and Finance at the London School of Economics and Political Science.
Before joining NICE, Alexia was a Director with Deloitte where she advised a range of clients in the healthcare and life science industries on policy and strategy development as well as programme implementation.
The NICE Board has the following
- Audit and Risk Committee
- Remuneration Committee